Next 10 |
2024-07-11 08:46:11 ET More on ProPhase Labs ProPhase Labs: Hidden Gem With An AI Kicker ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript ProPhase Labs Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on ProPhase Labs Historical...
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASD...
2024-06-06 08:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting May 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling idea...
2024-05-15 10:43:52 ET Summary ProPhase Labs is a diversified biotech company with profitable existing product lines and plans for expansion. The company's subsidiary, Nebula Genomics, offers whole genome sequencing and plans to leverage the data for AI applications. ProPhase'...
2024-05-09 16:47:09 ET ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Conference Call May 09, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive Officer Conference Call Participants ...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart...
2024-05-09 08:14:31 ET More on ProPhase Labs ProPhase Labs, Inc. 2023 Q4 - Results - Earnings Call Presentation ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript ProPhase Labs Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on ProPhase ...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Sma...
2024-05-08 14:03:30 ET More on ProPhase Labs ProPhase Labs, Inc. 2023 Q4 - Results - Earnings Call Presentation ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on ProPhase Labs Historical earnings data for ProPh...
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results...
News, Short Squeeze, Breakout and More Instantly...
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASD...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Sma...